In-Depth Analysis of the Competitive Landscape in the ADC Drug Industry: Moats, Growth Drivers, and Risk Perspectives
In-Depth Analysis of the Competitive Landscape in the ADC Drug Industry: Moats, Growth Drivers, and Risk Perspectives Core Summary The Chinese antibody-drug conjugate (ADC) industry is transitioning from a rapid expansion phase to an “innovation integration” phase. This transformation is driven by three core factors: stricter regulations (enhanced NMPA standards and NRDL price negotiations), technological … Read more